FindTrial
Sign In

The impact of anticoagulation on the long-term prognosis of patients with liver cirrhosis: A retrospective cohort study

The impact of anticoagulation on the long-term prognosis of patients with liver cirrhosis: A retrospective cohort study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116008
Enrollment
Unknown
Registered
2026-01-04
Start date
2026-01-04
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver cirrhosis

Interventions

Observation Group of Liver Cirrhosis:None

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Age >=18 years old; 2. Patients diagnosed with liver cirrhosis in our hospital from January 2019 to December 2024 (pathology/imaging); 3.Child-Pugh grade A/B; 4. Use anticoagulant drugs, etc.

Exclusion criteria

Exclusion criteria: 1. Age < 18 years old; 2. There are contraindications for anticoagulation, such as active bleeding, glomerular filtration rate less than 30ml/min, pregnancy or lactation, and inability to follow up, etc.

Design outcomes

Primary

MeasureTime frame
Death or end of follow-up;PVT Recanalization Rate;Newly diagnosed PVT rate;Occurrence of liver function decompensation event;—

Countries

China

Contacts

Public ContactZhao Hongyun

The Second Affiliated Hospital of Chongqing Medical University

zhychina@cqmu.edu.cn+86 23 6288 7681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026